Skip to content

Korro Bio, Inc.

KRRO · XNAS

CIK 1703647fmd_0GWQAXARVM0F556W192G12KT8FManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2017 to Sep 30, 2026, 36 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading